Mazumdar Claire bought BCAX
April 20, 2026 · Form 4 insider transaction
Mazumdar Claire bought 15,000 shares of Bicara Therapeutics Inc. at $3.79 per share, a transaction worth $56.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
15,000
Price
$3.79
Total value
$56.8K
InsiderMazumdar Claire
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 20, 2026
Filing dateApril 20, 2026
Shares owned after377,152
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.